Top Markets
Coin of the day
Altamira Therapeutics Ltd. Altamira Therapeutics Ltd.

Altamira Therapeutics Ltd.

CYTO
Classement en actions #38206
Altamira Therapeutics Ltd. is a biotechnology firm dedicated to pioneering new... Altamira Therapeutics Ltd. is a biotechnology firm dedicated to pioneering new treatments for critical medical needs that are currently underserved. Its marketed offerings include Bentrio, a non-pharmaceutical nasal spray designed for individual protection against prevalent airborne viruses and allergens. The company is also heavily invested in developing RNA therapeutics specifically for extrahepatic targets. This includes their preclinical OligoPhore and SemaPhore platforms, engineered for the effective delivery of oligonucleotides and mRNA. In its clinical-stage portfolio, AM-125 is undergoing Phase II trials for the intranasal treatment of vertigo. Additionally, Keyzilen and Sonsuvi are both in Phase III clinical development; Keyzilen is focused on acute inner ear tinnitus, and Sonsuvi addresses acute inner ear hearing loss. Established in 2003 and headquartered in Hamilton, Bermuda, Altamira Therapeutics conducts operations across Switzerland, the United States, Europe, and Australia. The company officially adopted the name Altamira Therapeutics Ltd. in July 2021, prior to which it was known as Auris Medical Holding Ltd.
Prix de l'action
$0.3
Dernière synchronisation: 2026-02-10
Capitalisation boursière
$1.13M
Changement (1 jour)
0.00%
Changement (1 an)
328.57%
Pays
BM
Échange Altamira Therapeutics Ltd. (CYTO)

Catégorie

Historique du prix de l'action pour Altamira Therapeutics Ltd. (CYTO)
Prix de clôture le plus élevé : $0.30 le 2026-02-01

Prix de clôture le plus bas : $502.51K le 2014-08-01
Historique du prix de l'action de Altamira Therapeutics Ltd. de 2014 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 0.00%
2025 -8.12%
2024 -93.34%
2023 -95.12%
2022 -83.04%
2021 -50.21%
2020 106.19%
2019 -84.04%
2018 -90.18%
2017 -62.31%
2016 -66.97%
2015 -7.95%
2014 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$505.24 29.45%
US
$846.09 29.68%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE